Must-See Earnings Estimates NYSE:KMT, NYSE:WLK, NASDAQ:KFRC, NASDAQ:EXC

0
86

KENNAMETAL (NYSE:KMT) EARNINGS INFORMATION (NYSE:KMT)

Kennametal last posted its quarterly earnings data on August 2nd, 2021. The industrial products company reported $0.53 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.13. The company had revenue of $515.97 million for the quarter, compared to the consensus estimate of $513.36 million. Its revenue for the quarter was up 36.1% on a year-over-year basis. Kennametal has generated $1.04 earnings per share over the last year ($0.64 diluted earnings per share) and currently has a price-to-earnings ratio of 57.0. Earnings for Kennametal are expected to grow by 44.57% in the coming year, from $1.75 to $2.53 per share. Kennametal has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, November 1st, 2021 based off prior year’s report dates.

IS KENNAMETAL A BUY RIGHT NOW? (NYSE:KMT)

7 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Kennametal in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “hold” Kennametal stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KMT, but not buy additional shares or sell existing shares.
Kennametal

WESTLAKE CHEMICAL (NYSE:WLK) EARNINGS INFORMATION (NYSE:WLK)

Westlake Chemical last posted its quarterly earnings results on August 3rd, 2021. The specialty chemicals company reported $4.04 EPS for the quarter, beating the consensus estimate of $3.80 by $0.24. The firm earned $2.86 billion during the quarter, compared to analysts’ expectations of $2.65 billion. Its revenue for the quarter was up 67.3% on a year-over-year basis. Westlake Chemical has generated $2.29 earnings per share over the last year ($3.30 diluted earnings per share) and currently has a price-to-earnings ratio of 24.5. Earnings for Westlake Chemical are expected to decrease by -22.14% in the coming year, from $12.24 to $9.53 per share. Westlake Chemical has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, November 2nd, 2021 based off prior year’s report dates.

IS WESTLAKE CHEMICAL A BUY RIGHT NOW? (NYSE:WLK)

14 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Westlake Chemical in the last year. There are currently 1 sell rating, 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “hold” Westlake Chemical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WLK, but not buy additional shares or sell existing shares.
Westlake Chemical

KFORCE (NASDAQ:KFRC) EARNINGS INFORMATION (NASDAQ:KFRC)

Kforce last announced its quarterly earnings data on August 3rd, 2021. The business services provider reported $1.00 EPS for the quarter, topping the consensus estimate of $0.91 by $0.09. Kforce has generated $2.62 earnings per share over the last year ($3.37 diluted earnings per share) and currently has a price-to-earnings ratio of 18.1. Earnings for Kforce are expected to grow by 8.39% in the coming year, from $3.10 to $3.36 per share. Kforce has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, November 1st, 2021 based off prior year’s report dates.

IS KFORCE A BUY RIGHT NOW? (NASDAQ:KFRC)

4 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Kforce in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “buy” Kforce stock.
Kforce

EXELON (NASDAQ:EXC) EARNINGS INFORMATION (NASDAQ:EXC)

Exelon last released its quarterly earnings results on August 4th, 2021. The reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.19. The company earned $7.92 billion during the quarter, compared to the consensus estimate of $6.83 billion. Its quarterly revenue was up 8.1% on a year-over-year basis. Exelon has generated $3.22 earnings per share over the last year ($1.11 diluted earnings per share) and currently has a price-to-earnings ratio of 42.9. Earnings for Exelon are expected to grow by 15.47% in the coming year, from $2.78 to $3.21 per share. Exelon has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, November 2nd, 2021 based off prior year’s report dates.

IS EXELON A BUY RIGHT NOW? (NASDAQ:EXC)

7 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Exelon in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Exelon stock.
Exelon